Home/Filings/3/0000921895-19-000847
3//SEC Filing

JFL Partners Fund LP 3

Accession 0000921895-19-000847

CIK 0001274792other

Filed

Mar 19, 8:00 PM ET

Accepted

Mar 20, 7:38 PM ET

Size

13.5 KB

Accession

0000921895-19-000847

Insider Transaction Report

Form 3
Period: 2019-03-13
Holdings
  • Common Stock

    (indirect: By: JFL Partners Fund LP)
    485,026
  • Common Stock

    (indirect: By LLC)
    677,236
JFL Partners Fund LP
10% OwnerOther
Holdings
  • Common Stock

    (indirect: By: JFL Partners Fund LP)
    485,026
  • Common Stock

    (indirect: By LLC)
    677,236
Lawler Joseph F.
10% OwnerOther
Holdings
  • Common Stock

    (indirect: By: JFL Partners Fund LP)
    485,026
  • Common Stock

    (indirect: By LLC)
    677,236
Holdings
  • Common Stock

    (indirect: By: JFL Partners Fund LP)
    485,026
  • Common Stock

    (indirect: By LLC)
    677,236
Holdings
  • Common Stock

    (indirect: By LLC)
    677,236
  • Common Stock

    (indirect: By: JFL Partners Fund LP)
    485,026
Footnotes (3)
  • [F1]This Form 3 is filed jointly by JFL Partners Fund LP ("JFL Partners"), JFL Capital Management LP ("JFL GP"), JFL Capital Holdings LLC ("JFL Holdings"), JFL Captal Management LLC ("JFL Capital Management") and Joseph F. Lawler (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities of the Issuer owned directly by other members of the Section 13(d) group and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. Further, each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.
  • [F2]Securities owned directly by JFL Partners. As the general partner of JFL Partners, JFL GP may be deemed to beneficially own the securities owned directly by JFL Partners. As the general parter of JFL GP, JFL Holdings may be deemed to beneficially own the securities owned directly by JFL Partners. JFL Capital Management, as the investment manager of JFL Partners, may be deemed to beneficially own the securities owned directly by JFL Partners. Dr. Lawler, as the managing member of both JFL Holdings and JFL Capital Management, may be deemed to beneficially own the securities owned directly by JFL Partners.
  • [F3]Securities held in an account separately managed by JFL Capital Management (the "JFL Managed Account"). JFL Capital Management, as the investment manager of the JFL Managed Account, may be deemed to beneficially own the securities held in the JFL Managed Account. Dr. Lawler, as the managing member of JFL Capital Management, may be deemed to beneficially own the securities held in the JFL Managed Account.

Issuer

MERRIMACK PHARMACEUTICALS INC

CIK 0001274792

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001626392

Filing Metadata

Form type
3
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 7:38 PM ET
Size
13.5 KB